EUVIMEDSkopri EUVIMED
LeitlinieOpen access

Canadian Urological Association guideline: Diagnosis, management, and followup of the incidentally discovered adrenal mass

Neal E Rowe, Ravi M Kumar, Nicola Schieda, Ferhan Siddiqi, Thomas McGregor, Kristen McAlpine, Philippe D Violette, Varun Bathini, Michael Eng, Jason Izard, Kunal Jana, Alexander Kutikov and 1 more

Canadian Urological Association Journal · 2023-01-26 · 17 (2) · 12-24

DOI: 10.5489/cuaj.8248 ↗

At a glance

Leitlinie in Canadian Urological Association Journal, published online on 2023-01-26. Written by Neal E Rowe and 12 co-authors. Institution: Division of Urology, University of Ottawa, Ottawa, ON, Canada. Cited 15 times so far (Crossref). The full text is freely available in PubMed Central.

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

INTRODUCTION Adrenal incidentalomas are adrenal masses greater than 1 cm in size that are detected on cross-sectional imaging performed for an unrelated indication.1 These lesions are common, estimated to be present in 4% of patients on imaging series, and up to 10% of the elderly population.2,3 Most of these lesions are benign nonfunctioning adrenocortical adenomas, with a minority being hormonally active or malignant. The evaluation and management of adrenal incidentalomas is a multidisciplinary process, relying on the expertise of family physicians, urologists, endocrinologists, and radiologists. In 2011, the Canadian Urological Association (CUA) released a guideline on the management of the incidentally discovered adrenal mass.4 Since then, there have been several clinical practice guidelines published by various endocrine, radiological, and surgical societies.5-8 A review by Maas et al compared these guidelines and found many points of discrepancy and controversy.9 Furthermore, in a letter to the editor from April 2021, McInnes et al suggested an important revision to the current CUA guideline.10 The purpose of this guideline is to provide an updated approach to the diagnosis, management, and followup of adrenal incidentalomas, with a special focus on the areas of discrepancy/controversy existing among the published guidelines from other associations.

Authors and institutions

  • Division of Urology, University of Ottawa, Ottawa, ON, Canada.
  • Division of Urology, University of Toronto, Toronto, ON, Canada.
  • Department of Radiology, University of Ottawa, Ottawa, ON, Canada.
  • Department of Endocrinology, Dalhousie University, Halifax, NS, Canada.
  • Department of Urology, Queen's University, Kingston, ON, Canada.
  • Urology, Credit Valley, Mississauga, ON, Canada.

Cite

APA

Rowe, N. E., Kumar, R. M., Schieda, N., Siddiqi, F., McGregor, T., McAlpine, K., Violette, P. D., Bathini, V., Eng, M., Izard, J., Jana, K., Kutikov, A., & Mayer, W. (2023). Canadian Urological Association guideline: Diagnosis, management, and followup of the incidentally discovered adrenal mass. Canadian Urological Association Journal, 17(2), 12-24. https://doi.org/10.5489/cuaj.8248

Vancouver

Rowe NE, Kumar RM, Schieda N, Siddiqi F, McGregor T, McAlpine K, et al. Canadian Urological Association guideline: Diagnosis, management, and followup of the incidentally discovered adrenal mass. Canadian Urological Association Journal. 2023;17(2):12-24. doi:10.5489/cuaj.8248

BibTeX
@article{Rowe2023,
  author = {Rowe, Neal E and Kumar, Ravi M and Schieda, Nicola and Siddiqi, Ferhan and McGregor, Thomas and McAlpine, Kristen and Violette, Philippe D and Bathini, Varun and Eng, Michael and Izard, Jason and Jana, Kunal and Kutikov, Alexander and Mayer, Wesley},
  title = {Canadian Urological Association guideline: Diagnosis, management, and followup of the incidentally discovered adrenal mass},
  journal = {Canadian Urological Association Journal},
  year = {2023},
  volume = {17},
  number = {2},
  pages = {12--24},
  doi = {10.5489/cuaj.8248}
}
Start for free →